Skip to main content

Table 7 Overall survival of the patients grouped by the combination of LDH and CEA levels

From: Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen

Group

PPTR group

Non-PPTR group

P

Group 1

22.23 (4.07–86.73)

16.23 (2.80–64.50)

<0.001

Group 2

20.13 (2.77–73.33)

13.17 (2.33–41.33)

0.188

Group 3

18.50 (4.70–25.50)

13.55 (3.47–44.43)

0.918

  1. Each value is presented as median followed by range in parentheses
  2. Group 1 consisted of patients who had normal LDH levels and CEA levels ≤70 ng/mL, group 2 consisted of patients with increased LDH levels and CEA levels ≤ 70 ng/mL, or patients with normal LDH levels and CEA levels >70 ng/mL, group 3 consisted of patients who had increased LDH levels and CEA levels >70 ng/mL. The overall survival was compared between PPTR and non-PPTR group, and the differences were analyzed using the log-rank test
  3. PPTR palliative primary tumor resection, CEA carcinoembryonic antigen, LDH lactate dehydrogenase